Soluble Interleukin-2 Receptor Levels in Patients With Dilated Cardiomyopathy
Authors:
- 1 February 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (3) , 631-634
Abstract
Background There is evidence that autoimmunity plays an important role in the initiation and progression of myocardial injury in dilated cardiomyopathy. Abnormalities of both cellular and humoral immunity have been described in this disease. Soluble interleukin-2 receptor (sIL-2R) levels in the serum reflect activation of T lymphocytes in the periphery or in tissues. The present study explored the possibility that activation of cellular immunity is frequent in patients with idiopathic dilated cardiomyopathy and may have functional consequences. Methods and Results Serum sIL-2R levels were determined with an enzyme-linked immunosorbent assay in 50 dilated cardiomyopathy patients, 30 patients with ischemic heart disease, and 22 normal control subjects. In addition, the presence of anti–β-receptor and antimyosin antibodies was sought in the serum of cardiomyopathy patients. High sIL-2R levels (>1400 pg/mL) were found in 38% of the dilated cardiomyopathy patients but only 6% of the ischemic heart disease patients. The group of sIL-2R–positive patients was characterized by higher average age, a higher percentage of women, and more severe disease (lower ejection fraction, higher left ventricular filling pressures, and lower cardiac output). Although the prevalence of cardiac autoantibodies did not correlate with the presence of high sIL-2R levels, higher titers of autoantibodies were found predominantly in the sIL-2R–positive group. Conclusions T-lymphocyte activation, as reflected in elevated sIL-2R levels, is frequent in patients with dilated cardiomyopathy and is associated with more severe disease. Cellular and humoral immune activation may correlate with progression of the disease process.Keywords
This publication has 24 references indexed in Scilit:
- Neointimal coverage of stents in human coronary arteries observed by angioscopyJACC, 1994
- Cell infiltration caused deterioration in the prognosis of patients with clinical diagnosis of dilated cardiomyopathy (DCM): Application of biopsy criteria of myocarditis to 42 autopsy casesHeart and Vessels, 1993
- Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factorsAmerican Heart Journal, 1992
- Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection.Annals of the Rheumatic Diseases, 1991
- Soluble interleukin-2 receptor in sera of patients with Graves' diseaseJournal of Autoimmunity, 1991
- Increased Level of HLA-DR-Expressing T Lymphocytes in Peripheral Blood from Patients with Idiopathic Dilated CardiomyopathyCardiology, 1991
- THE MULTI-SUBUNIT INTERLEUKIN-2 RECEPTORAnnual Review of Biochemistry, 1989
- T-lymphocyte subsets in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980